CRNC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cerence Inc (CRNC) is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are some positive indicators like hedge fund buying and a significant YoY revenue increase, the company's financial performance is weak with declining net income and EPS. Technical indicators are mixed, and analysts have lowered price targets, citing limited growth and profitability. The lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals further support a hold recommendation.
The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 41.216, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 7.751, with key resistance at 8.125 and support at 7.376.
Hedge funds have increased their buying activity by 348.02% over the last quarter. Revenue has grown significantly YoY (126.10%), and gross margin has improved by 35.12%.
Insiders have increased their selling activity by 8776.61% over the last month. Net income and EPS have dropped significantly YoY (-78.43% and -78.95%, respectively). Analysts have lowered price targets, citing limited growth and profitability. No recent news or congress trading data to act as a catalyst.
In Q1 2026, revenue increased by 126.10% YoY to $115.08M. However, net income dropped by -78.43% YoY to -$5.24M, and EPS declined by -78.95% YoY to -0.12. Gross margin improved to 86.33%, up 35.12% YoY.
Analysts have lowered price targets recently. Goldman Sachs reduced the target from $11 to $8, maintaining a Neutral rating, citing limited growth and profitability. TD Cowen also lowered its target from $13 to $12, maintaining a Hold rating, citing a noisy financial outcome and potential EBITDA shortfall for the rest of FY26.
